Vasomotor hot flashes and heart rate variability: A placebo-controlled trial of postmenopausal hormone therapy

Menopause

Volumn 19, Issue 1, 2012, Pages 82-88

  Lantto, Hanna ^a   Haapalahti, Petri ^a   Tuomikoski, Pauliina ^a   Viitasalo, Matti ^a   Väänänen, Heikki ^b   Sovijärvi, Anssi R A ^a   Ylikorkala, Olavi ^a   Mikkola, Tomi S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b AALTO UNIVERSITY   (Finland)

Author keywords

Cardiovascular function; Electrocardiography; Hot flash; Menopause; Vasomotor symptom

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADD ON THERAPY; ADULT; AMBULATORY MONITORING; ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; ESTROGEN THERAPY; FEMALE; GEL; HEART ARRHYTHMIA; HEART RATE; HEART RATE VARIABILITY; HORMONAL THERAPY; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR PREMATURE BEAT; TREATMENT OUTCOME; VASOMOTOR DISORDER;

ADMINISTRATION, CUTANEOUS; ARRHYTHMIAS, CARDIAC; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART RATE; HOT FLASHES; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE;

EID: 84655163345     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318221bae8     Document Type: Article

References (35)

1. Svartberg J, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms and mortality: the Rancho Bernardo study. Menopause 2009;16:888-891.
2. Allison MA, Manson JE, Aragaki A, et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause 2010;17: 1136-1145.
3. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause 2010;17:256-261.
4. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health 2007;10:247-257.
5. Hoikkala H, Haapalahti P, Viitasalo M, et al. Association between vasomotor hot flashes and heart rate variability in recently postmenopausal women. Menopause 2010;17:315-320.
6. Tuomikoski P, Haapalahti P, Ylikorkala O, Mikkola TS. Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently postmenopausal women. Ann Med 2010;42:216-222.
7. Nelson HD. Menopause. Lancet 2008;371:760-770. (Pubitemid 351288876)
8. Wolbrette D, Naccarelli G, Curtis A, Lehmann M, Kadish A. Gender differences in arrhythmias. Clin Cardiol 2002;25:49-56. (Pubitemid 34111554)
9. Rivero A, Curtis AB. Sex differences in arrhythmias. Curr Opin Cardiol 2010;25:8-15.
10. Gokce M, Karahan B, Yilmaz R, Orem C, Erdol C, Ozdemir S. Long term effects of hormone replacement therapy on heart rate variability, QT interval, QT dispersion and frequencies of arrhythmia. Int J Cardiol 2005;99:373-379. (Pubitemid 40363986)
11. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005;10:88-101. (Pubitemid 40476672)
12. Brockbank CL, Chatterjee F, Bruce SA, Woledge RC. Heart rate and its variability change after the menopause. Exp Physiol 2000;85:327-330. (Pubitemid 30333046)
13. Mercuro G, Podda A, Pitzalis L, et al. Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am J Cardiol 2000;85:787-789, A9. (Pubitemid 30133410)
14. Rosano GM, Patrizi R, Leonardo F, et al. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol 1997;80:815-817. (Pubitemid 27413605)
15. Yildirir A, Kabakci G, Yarali H, et al. Effects of hormone replacement therapy on heart rate variability in postmenopausal women. Ann Noninvasive Electrocardiol 2001;6:280-284. (Pubitemid 33043678)
16. Farag NH, Nelesen RA, Parry BL, Loredo JS, Dimsdale JE, Mills PJ. Autonomic and cardiovascular function in postmenopausal women: the effects of estrogen versus combination therapy. Am J Obstet Gynecol 2002;186:954-961.
17. Christ M, Seyffart K, Tillmann HC, Wehling M. Hormone replacement in postmenopausal women: impact of progestogens on autonomic tone and blood pressure regulation. Menopause 2002;9:127-136. (Pubitemid 34194108)
18. Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens. Pacing Clin Electrophysiol 2005;28:S172-S177. (Pubitemid 40171110)
19. Tuomikoski P, Ebert P, Groop PH, et al. Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol 2009;113:902-908.
20. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J ClinOncol 2001; 19:4280-4290. (Pubitemid 33096775)
21. Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J. Initial 17A-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726-731. (Pubitemid 30210060)
22. Tuomikoski P, Mikkola TS, Hämäläinen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes. Menopause 2010;17:145-151.
23. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-1065.
24. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84: 482-492.
25. Tuomikoski P, Ebert P, Groop PH, et al. Effect of hot flushes on vascular function: a randomized controlled trial. Obstet Gynecol 2009;114:777-785.
26. Willich SN. Circadian variation and triggering of cardiovascular events. Vasc Med 1999;4:41-49. (Pubitemid 29166741)
27. Martino TA, Sole MJ. Molecular time: an often overlooked dimension to cardiovascular disease. Circ Res 2009;105:1047-1061.
28. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D. Hot flushes. Lancet 2002;360:1851-1861. (Pubitemid 35449427)
29. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005;8:3-63. (Pubitemid 41232429)
30. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation 2010;121:1904-1911.
31. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) research group. JAMA 1998;280:605-613. (Pubitemid 28502636)
32. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 2009;16:639-643.
33. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534. (Pubitemid 36951364)
34. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619. (Pubitemid 34175253)
35. Teede HJ. Sex hormones and the cardiovascular system: effects on arterial function in women. Clin Exp Pharmacol Physiol 2007;34:672-676. (Pubitemid 46953117)